<div class="content gradient-lighter"><div class="content-header"><div class="container"><button id="button-back"><div class="w-full h-full @container flex items-center justify-center gap-2"><div class="text-white aspect-square w-full max-w-[min(100cqmin,72px)]"><svg width="15" height="15" viewBox="0 0 15 15" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M6.85355 3.14645C7.04882 3.34171 7.04882 3.65829 6.85355 3.85355L3.70711 7H12.5C12.7761 7 13 7.22386 13 7.5C13 7.77614 12.7761 8 12.5 8H3.70711L6.85355 11.1464C7.04882 11.3417 7.04882 11.6583 6.85355 11.8536C6.65829 12.0488 6.34171 12.0488 6.14645 11.8536L2.14645 7.85355C1.95118 7.65829 1.95118 7.34171 2.14645 7.14645L6.14645 3.14645C6.34171 2.95118 6.65829 2.95118 6.85355 3.14645Z" fill="currentColor" fill-rule="evenodd" clip-rule="evenodd"></path></svg></div></div></button><div class="title">Guidelines</div></div><div class="subtitle"></div></div><div class="pt-2 presentation_wrapper"><div data-full-bleed="true" class="flex flex-col items-center justify-center flex-1 gap-2"><div class="w-full border-b border-b-4 border-[#4c9be6] "><div class="toggable-buttons-container tabbed"><button data-group="d762360c-249d-49ec-8117-b365b5fd4059" data-slide="0" data-toggable-button="true" class="toggable-button">Guidelines</button><button data-group="d762360c-249d-49ec-8117-b365b5fd4059" data-slide="1" data-toggable-button="true" class="toggable-button">Psychotherapy</button><button data-group="d762360c-249d-49ec-8117-b365b5fd4059" data-slide="2" data-toggable-button="true" class="toggable-button">Pharmacotherapy</button></div></div><div class="w-full"><div id="toggable-container" class="presentation_wrapper" data-group="d762360c-249d-49ec-8117-b365b5fd4059" data-slide="0"><div class="panel"><h2>Summary of US Guidelines for Pharmacotherapy<a aria-describedby="ref-marker">1</a></h2><div class="@container flex flex-col gap-y-1 text-[#6e777e] gap-x-1"><div class="grid grid-cols-1 @md:grid-cols-[repeat(5,1fr)]"><div class="col-span-1 p-2 bg-[#0b5079] text-[#eaeded] flex flex-col items-center justify-center"><span>Drug/Class</span></div><div class="col-span-1 p-2 bg-[#0b5079] text-[#eaeded] flex flex-col items-center justify-center"><span>FDA Approved</span></div><div class="col-span-1 p-2 bg-[#0b5079] text-[#eaeded] flex flex-col items-center justify-center"><span>VA/DoD Guidelines (2023)<a aria-describedby="ref-marker">2</a></span></div><div class="col-span-1 p-2 bg-[#0b5079] text-[#eaeded] flex flex-col items-center justify-center"><span>APA Guidelines (2004)<a aria-describedby="ref-marker">3</a></span></div><div class="col-span-1 p-2 bg-[#0b5079] text-[#eaeded] flex flex-col items-center justify-center"><span>Drug/Class<a aria-describedby="ref-marker">4</a></span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Setraline</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Yes</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Paroxetine</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Yes</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>+</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>+</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Fluoxetine</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>-</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Other SSRIs<a aria-describedby="ref-marker">a</a></span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>-</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Insufficient evidence</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Venlafaxine</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>-</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>+</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Quetiapine</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>-</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>-</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Risperidone</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>-</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>-</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Insufficient evidence</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Insufficient evidence</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Trcyclic antidepressants<a aria-describedby="ref-marker">a</a></span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>-</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Insufficient evidence + weak<a aria-describedby="ref-marker">c</a></span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>Prazosin<a aria-describedby="ref-marker">b</a></span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>-</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>- weak</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>NA</span></div><div class="col-span-1 p-2 bg-[#c1daed] flex flex-col items-center justify-center"><span>NA</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>Benzodiazepines<a aria-describedby="ref-marker">a</a></span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>-</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>--</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div><div class="flex flex-col items-center justify-center col-span-1 p-2 bg-[#d5e5f0]"><span>NA</span></div></div></div><dl><dt>+</dt><dd>recommendation for</dd><dt>-</dt><dd>recommendation against</dd><dt>--</dt><dd>strong recommendation against</dd><dt>NA</dt><dd>not addressed</dd><dt>a</dt><dd>Class of medications</dd><dt>b</dt><dd>First-line treatment for nightmares in PTSD according to AASM and modified from Merians AN et al, 2023</dd><dt>c</dt><dd>Weak recommendation for imipramine and amitriptyline only (adapted from Merians AN et al, 2023).</dd></dl></div></div><div id="toggable-container" class="presentation_wrapper" data-group="d762360c-249d-49ec-8117-b365b5fd4059" data-slide="1"><div class="panel"><p>Psychotherapy has demonstrated clinical benefits for PTSD, including reduced symptom severity and improved remission rates<a aria-describedby="ref-marker">2</a><a aria-describedby="ref-marker">3</a><a aria-describedby="ref-marker">4</a>. Several considerations must be made to utilize psychotherapy effectively, including<a aria-describedby="ref-marker">5</a>:</p><ul class="list"><li>Treatment cost</li><li>Resource availability</li><li>Patient preference</li><li>Comorbidities</li></ul></div><div class="panel"><h3>Cognitive Behavioral Therapy (CBT) for PTSD</h3><p>International and US guidelines strongly recommend trauma-focused cognitive behavioral therapy (TF-CBT) as the first-line treatment for PTSD<a aria-describedby="ref-marker">2</a><a aria-describedby="ref-marker">6</a>. Research shows that TF-CBT has a significantly greater effect on individuals with PTSD compared to other psychotherapies and pharmacotherapies<a aria-describedby="ref-marker">3</a>. </p><p>Cognitive behavioral therapy (CBT) emphasizes the connection between thoughts, feelings, and behaviors, highlighting how changes in one area can enhance functioning in others. For instance, modifying negative thought patterns can lead to healthier behaviors and better emotional regulation. CBT addresses current issues and symptoms and is typically administered over 12-16 sessions, either individually or in group settings<a aria-describedby="ref-marker">7</a>.</p><h3>Prolonged Exposure (PE) for PTSD</h3><p>Prolonged Exposure (PE) is a form of Cognitive Behavioral Therapy (CBT) that helps patients gradually face trauma-related memories, feelings, and situations they have been avoiding. PE works by having patients confront their fears, which reduces PTSD symptoms and helps them regain control in their daily lives<a aria-describedby="ref-marker">1</a><a aria-describedby="ref-marker">8</a>. </p><h3>Cognitive Processing Therapy (CPT) for PTSD</h3><p>Cognitive Processing Therapy (CPT) is another type of CBT designed to help patients modify and challenge unhelpful beliefs related to their trauma. This 12-session therapy focuses on evaluating and changing distressing thoughts that have persisted since the trauma. By altering these thoughts, patients can change their emotional responses. CPT helps patients develop a new understanding of the traumatic event, reducing its negative impact on their current life<a aria-describedby="ref-marker">1</a><a aria-describedby="ref-marker">9</a><a aria-describedby="ref-marker">10</a>. </p><h3>Eye Movement Desensitization and Reprocessing (EMDR) for PTSD</h3><p>Eye Movement Desensitization and Reprocessing (EMDR) is a psychotherapy for PTSD that assists patients in processing upsetting memories, thoughts, and feelings related to trauma. During EMDR sessions, patients focus on an external stimulus, such as alternating tones through headphones or alternating hand taps, while recalling the distressing memory. This dual focus helps patients reprocess the traumatic memory, leading to changes in how they experience and understand it<a aria-describedby="ref-marker">1</a><a aria-describedby="ref-marker">11</a>. </p></div></div><div id="toggable-container" class="presentation_wrapper" data-group="d762360c-249d-49ec-8117-b365b5fd4059" data-slide="2"><div class="panel"><p>Most patients with PTSD are treated with a combination of psychotherapy and pharmacotherapy<a aria-describedby="ref-marker">5</a>. Pharmacotherapy is crucial in managing PTSD, and starting treatment early can<a aria-describedby="ref-marker">12</a><a aria-describedby="ref-marker">13</a><a aria-describedby="ref-marker">14</a>: </p><ul class="list"><li>Improve core symptoms</li><li>Reduce associated disability</li><li>Enhance long-term outcomes</li></ul></div><div class="panel"><h3>Recommended Medications</h3><p>Guidelines recommend SSRIs (Selective Serotonin Reuptake Inhibitors) as the first-line pharmacologic treatment, when necessary, with <em>sertraline</em> and <em>paroxetine</em> being the only FDA-approved options<a aria-describedby="ref-marker">2</a><a aria-describedby="ref-marker">15</a>. The SNRI (Serotonin-Norepinephrine Reuptake Inhibitor) venlafaxine is also recommended<a aria-describedby="ref-marker">15</a>. Approximately <em>52%</em> of patients undergoing pharmacotherapy are treated with either SSRIs or SNRIs<a aria-describedby="ref-marker">16</a>. </p><p>Long-term pharmacotherapy (lasting more than 12 weeks) may be necessary to sustain improvements made during the initial treatment period<a aria-describedby="ref-marker">14</a>. </p><h3>Polypharmacy in PTSD</h3><ul><li>Due to the limited efficacy and options of FDA-approved treatments, many patients require multiple medications<a aria-describedby="ref-marker">17</a>. </li><li>On average, patients with PTSD are prescribed 1.6 medications for their condition<a aria-describedby="ref-marker">18</a>. </li><li>Common combinations include SSRIs, anxiolytics, and benzodiazepines to address depression and sleep disturbances<a aria-describedby="ref-marker">17</a>. </li></ul></div></div></div></div><div class="references panel"><h4 class="uppercase">References </h4><div class="pl-3"><ol class="list"><li>Merians AN, Spiller T, Harpaz-Rotem I, Krystal JH, Pietrzak RH. Post-traumatic Stress Disorder. Med Clin North Am. 2023;107(1):85-99. doi:10.1016/j.mcna.2022.04.003</li><li>Yehuda R, Hoge CW, McFarlane AC, et al. Post-traumatic stress disorder. <em>Nat Rev Dis Primers</em>. 2015;1:15057. Published 2015 Oct 8.</li><li>Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments. <em>Depress Anxiety</em>. 2016;33(9):792-806. doi:10.1002/da.22511</li><li>Mavranezouli I, Megnin-Viggars O, Daly C, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. <em>Psychol Med</em>. 2020;50(4):542-555. doi:10.1017/S0033291720000070</li><li>Martin A, Naunton M, Kosari S, Peterson G, Thomas J, Christenson JK. Treatment Guidelines for PTSD: A Systematic Review. <em>J Clin Med</em>. 2021;10(18):4175. Published 2021 Sep 15. doi:10.3390/jcm10184175</li><li>Bisson JI, Berliner L, Cloitre M, et al. The International Society for Traumatic Stress Studies New Guidelines for the Prevention and Treatment of Posttraumatic Stress Disorder: Methodology and Development Process. <em>J Trauma Stress</em>. 2019;32(4):475-483. doi:10.1002/jts.22421</li><li>American Psychological Association. Cognitive behavioral therapy (CBT) for treatment of PTSD. American Psychological Association. https://www.apa.org/ptsd-guideline/treatments/cognitive-behavioral-therapy. Published July 31, 2017.</li><li>U.S. Department of Veterans Affairs. Prolonged Exposure for PTSD - PTSD: National Center for PTSD. Va.gov. Published 2014. <a href="https://www.ptsd.va.gov/understand_tx/prolonged_exposure.asp">https://www.ptsd.va.gov/understand_tx/prolonged_exposure.asp</a></li><li>U.S. Department of Veterans Affairs. Cognitive Processing Therapy for PTSD - PTSD: National Center for PTSD. Va.gov. Published 2014. <a href="https://www.ptsd.va.gov/understand_tx/cognitive_processing.asp">https://www.ptsd.va.gov/understand_tx/cognitive_processing.asp</a></li><li>American Psychological Association. Cognitive processing therapy (CPT). American Psychological Association. https://www.apa.org/ptsd-guideline/treatments/cognitive-processing-therapy. Published July 31, 2017.</li><li>U.S. Department of Veterans Affairs. Eye Movement Desensitization and Reprocessing (EMDR) for PTSD - PTSD: National Center for PTSD. Va.gov. Published 2014. <a href="https://www.ptsd.va.gov/understand_tx/emdr.asp">https://www.ptsd.va.gov/understand_tx/emdr.asp</a></li><li>Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). <em>Cochrane Database Syst Rev</em>. 2006;2006(1):CD002795. Published 2006 Jan 25. doi:10.1002/14651858.CD002795.pub2</li><li>Williams T, Phillips NJ, Stein DJ, Ipser JC. Pharmacotherapy for post traumatic stress disorder (PTSD). <em>Cochrane Database Syst Rev</em>. 2022;3(3):CD002795. Published 2022 Mar 2. doi:10.1002/14651858.CD002795.pub3</li><li>Davis LL, Frazier EC, Williford RB, Newell JM. Long-term pharmacotherapy for post-traumatic stress disorder. <em>CNS Drugs</em>. 2006;20(6):465-476. doi:10.2165/00023210-200620060-00003</li><li>American Psychological Association. Treatments for PTSD. https://www.apa.org. https://www.apa.org/ptsd-guideline/treatments. Published June 2020.</li><li>Cook JM, Zeber JE, Simiola V, et al. Comparisons Between Patients Diagnosed with PTSD in Primary Care Versus Mental Health Care in Five Large Civilian Health Care Systems<em>J Clin Psychol Med Settings</em>. 2021;28(2):221-228. doi:10.1007/s10880-020-09706-8</li><li>Krystal JH, Davis LL, Neylan TC, et al. It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group [published correction appears in Biol Psychiatry. 2018 Feb 1;83(3):296. doi: 10.1016/j.biopsych.2017.11.003]. <em>Biol Psychiatry</em>. 2017;82(7):e51-e59. doi:10.1016/j.biopsych.2017.03.007</li><li>Otsuka data on file</li></ol></div></div></div></div>